Traders should anticipate significant share price pressure due to the dilutive nature of this offering and the overhang from the 150% warrant coverage. Monitor for insider selling patterns and watch for future capital raises given the company's need for working capital. The lack of a specified use for debt repayment suggests ongoing operational cash burn.
Price Chart
Executive Summary
Entera Bio is raising capital through a private placement of $10.5 million in unregistered securities, consisting of ordinary shares and pre-funded warrants at $1.2775 per share, accompanied by ordinary share warrants with a 150% coverage and an exercise price of $1.24. The proceeds will be used for working capital and general corporate purposes, representing a significant dilutive event for existing shareholders.
Key Financial Metrics
Key Facts
- Entera Bio is conducting a private placement of $10.5 million in unregistered securities
- The offering includes ordinary shares, pre-funded warrants, and ordinary share warrants with 150% coverage
- The per share purchase price is $1.2775, with ordinary share warrants exercisable at $1.24 per share
- Proceeds will be used for working capital and general corporate purposes
- The transaction represents significant dilution to existing shareholders
Financial Impact
$10.5 million in gross proceeds with significant dilution to existing shareholders
Risk Factors
- Significant shareholder dilution from the issuance of new shares and warrants
- Future share price pressure from the overhang of warrants exercisable at $1.24
- Potential for additional dilutive offerings if the company requires more working capital
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001178913-26-002001 |
| Exhibit: exhibit_10-4.htm | 0001178913-26-002001 |
| Exhibit: exhibit_10-3.htm | 0001178913-26-002001 |
| Exhibit: exhibit_10-2.htm | 0001178913-26-002001 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 14, 2026 12d ago | DEF 14A | $2.77 | awaiting T+60 | — | $2.86 (+3.25%) |
Oct 6, 2026 20d ago | 8-K | $2.53 | awaiting T+60 | — | $2.86 (+13.04%) |
Aug 27, 2026 8w ago | Press Release | $3.08 | awaiting T+60 | — | $2.86 (−7.14%) |
Aug 18, 2026 9w ago | 8-K | $2.89 | awaiting T+60 | — | $2.86 (−1.04%) |
Aug 7, 2026 11w ago | Press Release | $3.04 | awaiting T+60 | — | $2.86 (−5.92%) |
Jul 29, 2026 12w ago | Press Release | $3.00 $3.02 | ▲ +0.67% | ▼ −4.06% | $2.86 (−4.67%) |
Jun 16, 2026 18w ago | Press Release | $1.18 $2.79 | ▲ +136.44% | ▲ +135.44% | $2.86 (+142.37%) |
May 28, 2026 21w ago | Press Release | $1.22 $3.23 | ▲ +164.75% | ▲ +163.02% | $2.86 (+134.43%) |
May 18, 2026 23w ago | EFFECT | $1.23 $2.80 | ▲ +127.64% | ▲ +122.79% | $2.86 (+132.52%) |
May 8, 2026 24w ago | S-3 | $1.17 $2.81 | ▲ +140.17% | ▲ +135.78% | $2.86 (+144.44%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers